No benefit of vorapaxar on walking performance in patients with intermittent claudication
Sign Up to like & getrecommendations! Published in 2021 at "Vascular Medicine"
DOI: 10.1177/1358863x211042082
Abstract: Background: The effect of pharmacologic agents in improving walking and quality of life measures in patients with intermittent claudication (IC) is variable. The objective of this study was to investigate the effect of the novel… read more here.
Keywords: patients intermittent; benefit vorapaxar; vorapaxar; walking performance ... See more keywords